Sterling Capital Management’s Akero Therapeutics AKRO Stock Holding History

Sterling Capital Management’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-169	Closed	-$8.02K	–	3233
2025 Q3	$8.02K	Hold	169	–	–	﹤0.01%	2610
2025 Q2	$9.02K	Sell	169 -913	-84%	-$41.5K	﹤0.01%	2196
2025 Q1	$43.8K	Sell	1,082 -707	-40%	-$30K	﹤0.01%	1454
2024 Q4	$49.8K	Buy	1,789 +1,582	+764%	+$47.9K	﹤0.01%	1608
2024 Q3	$5.94K	Buy	+207	New	+$5.4K	﹤0.01%	1694

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sterling Capital Management's AKRO Position: Q4 2025 in Review

Sterling Capital Management sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 169 shares — an estimated $8.02K sold.

Sterling Capital Management first reported a position in AKRO in Q3 2024 and held it in 5 quarters. The position peaked at $49.8K in Q4 2024. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

Sterling Capital Management reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
Sterling Capital Management sold 169 Akero Therapeutics shares in Q4 2025, an estimated $8.02K.
Sterling Capital Management first reported a position in Akero Therapeutics in Q3 2024 and held it in 5 quarters.
Sterling Capital Management's Akero Therapeutics position peaked at $49.8K in Q4 2024.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Sterling Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.